BPC 157: Experimental Peptide Creates Risk for Athletes The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times FDA Compliance for Peptide Therapy and BPC 157 Holt Law Peptides Lack Reliable Safety Information, Watchdog Warns